
Parspas 20mg/325mg Tablet
Marketer
Nemi Pharmaceuticles
Salt Composition
Dicyclomine (20mg) + Paracetamol (325mg)
Overview Parspas 20mg/325mg Tablet
Combiflex 20mg/325mg tablets offer relief from abdominal discomfort. This dual-action formulation eases stomach and intestinal cramping through muscle relaxation and by inhibiting pain and fever-inducing chemicals. Combiflex is administered as directed by your physician, with or without food (though taking it with food may minimize stomach upset). Dosage depends on individual response and condition; consistent use, as prescribed, is crucial to prevent symptom recurrence and potential worsening. Inform your doctor of all other medications you are using, as interactions are possible. Common, generally transient side effects include nausea, dry mouth, blurred vision, fatigue, and anxiety. Report any concerning side effects immediately. Drowsiness may occur; avoid driving or tasks requiring alertness until its impact is known. Alcohol should be avoided due to potential increased drowsiness. Prior to commencing treatment, disclose any kidney or liver conditions for appropriate dosage adjustment. Breastfeeding mothers should also inform their physician.
Uses of Parspas 20mg/325mg Tablet
Managing abdominal discomfort
Major Benefits of Parspas 20mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Parspas 20mg/325mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Parspas 20mg/325mg Tablet:
- Nausea
- Dryness in mouth
- Blurred vision
- Sleepiness
- Weakness
- Nervousness
How to use Parspas 20mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 20mg/325mg Parspas Tablet whole; do not break, chew, or crush it. This medication can be administered with or without food, although consistent timing is recommended.
How Parspas 20mg/325mg Tablet works:
Combining dicyclomine (20mg) and paracetamol (325mg), Parspas tablets offer relief from abdominal pain and cramping. The anticholinergic dicyclomine eases stomach and intestinal muscle spasms, alleviating cramping, pain, bloating, and discomfort by reducing involuntary muscle contractions. Paracetamol, an analgesic, mitigates pain by inhibiting the release of pain-signaling chemicals.
SAFETY ADVICE
AlcoholUNSAFE
Combining Parspas 20mg/325mg tablets with alcohol is hazardous.
PregnancySAFE IF PRESCRIBED
The use of Parspas 20mg/325mg Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to the fetus; nonetheless, clinical data from human trials are scarce.
Breast feedingCONSULT YOUR DOCTOR
The use of Parspas 20mg/325mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability may be affected by Parspas 20mg/325mg Tablet; however, this effect is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Parspas 20mg/325mg tablets cautiously. Dosage modification for Parspas 20mg/325mg tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Parspas 20mg/325mg tablets cautiously, potentially requiring dose modification. Medical advice is essential. Parspas 20mg/325mg tablets are contraindicated in individuals with severe or active liver disease.
What if you forget to take Parspas 20mg/325mg Tablet :
Should you forget a Parspas 20mg/325mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Parspas 20mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
